<?xml version="1.0" encoding="UTF-8" standalone="yes"?><trialResultsOutput hits="1" offset="0" totalResults="1"><SearchResults><Trial Id="125398"><Indications><Indication>Pneumonia</Indication></Indications><CompaniesSponsor><Company>Nippon Medical School Foundation</Company></CompaniesSponsor><Countries><Country>Japan</Country></Countries><DateChangeLast>2018-07-18T00:00:00Z</DateChangeLast><DateStart>2010-04-01T00:00:00Z</DateStart><Identifiers><Identifier>JPRN-UMIN000003371</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>Hi-Lo Evac endotracheal tube alone</Intervention><Intervention>TaperGuard evac endotracheal tube alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>240</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The aim of this study was to investigate the difference of the VAP incidence by two types of tracheal tubes with subglottic secretion drainage [ 1411357 ].</Teaser><TrialCategories><Category>Medical device</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Pneumonia - Assessment of Disease Incidence</EndpointIndex><EndpointIndex>Pneumonia - Assessment of Mortality/Death Rates</EndpointIndex><EndpointIndex>Pneumonia - Assessment of complications</EndpointIndex><EndpointIndex>Pneumonia - Health Economic Assessments - Assessment of cost effectiveness</EndpointIndex><EndpointIndex>Pneumonia - Requirement of Ventilatory Support/Intervention</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Male</Term><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>A Randomized Clinical Trial of the Tracheal Tube with Subglottic Secretion Drainage for Preventing Ventilator-associated Pneumonia (VAP)</TitleDisplay><PatientSegmentTerms><PatientSegment>Pneumonia - Subjects at risk of developing disease - Hospitalized subjects/subjects on ventilator</PatientSegment></PatientSegmentTerms><PrimaryCompletionDate/><NumberOfSites>1</NumberOfSites><ContactNames><Name>Nobuyuki Saito</Name></ContactNames></Trial></SearchResults></trialResultsOutput>